Monthly Factsheet

Monthly factsheet as at 28 February 2026 for Fidelity Emerging Markets Limited (LEI: 213800HWWQPUJ4K1GS84) is available on the company's website. Copies have been submitted to the UK Listing Authority and will shortly be available for inspection on the National Storage Mechanism (typically within two business days).

Analysis

Closed-end EM investment trusts (the structure underlying this factsheet) create predictable, tradeable disconnects between NAV and share price that widen in risk-off and narrow when transparency or distribution policies change. A modest governance signal or even repeat monthly reporting can shave 150–400bp off an average discount within 3–6 months as retail/institutional arbitrage re-enters; this is a more reliable, short-to-intermediate-term catalyst than broad macro calls.

Second-order: persistent ETF dominance in EM has hollowed out liquidity in mid/small caps and concentrated index risk in a handful of large caps, amplifying episodic mispricings that active, concentrated EM managers can exploit. If index flows reverse or local liquidity normalizes, expect 5–15% idiosyncratic rebounds in names neglected by passive instruments over a 1–12 month window — a fertile environment for pair trades that monetize reversion without taking directional beta.

Key risks are asymmetric: a sudden EM FX shock (>10% depreciation in a major currency within 1–3 months) or rapid global rates repricing can widen discounts and erase NAV gains quickly; regulatory moves (capital controls or UK listing rule tweaks) would be binary and can take months to resolve. Contrarian payoff: the market currently treats EM exposure homogenously — selectively financing active closed-end trusts and overlayed hedges captures both discount compression and manager-level alpha while capping tail risk.

Key Decisions for Investors

• Long closed-end EM trust vs passive ETF pair: Buy Fidelity Emerging Markets closed-end trust (LSE listing) and short VWO (Vanguard FTSE Emerging Markets ETF) sized to net zero beta. Entry: when trust trades >5% discount to reported NAV. Timeframe: 3–12 months. Target: discount compression to 0–2% and outperformance of 6–12%; downside: further discount widening to 12% implies ~-5% drawdown — hedge with a 3–6 month put on VWO if volatility cheap.
• Tactical China overweight via large-cap re-rating: Buy FXI (iShares China Large-Cap ETF) or A50 futures on Chinese policy stimulus signals. Entry: on confirmation of targeted stimulus (credit or property policy) within next 1–3 months. Timeframe: 1–6 months. Risk/reward: asymmetric — 20–30% upside if stimulus triggers re-rating, capped by idiosyncratic regulatory risk; size as 3–5% of portfolio.
• Vol/Hedge protection: Buy put spreads on EEM (Dec 2026) to protect concentrated EM long exposures. Structure: buy EEM Dec 2026 1x put spread (buy 1 put, sell lower strike put) to limit cost. Timeframe: 6–12 months. Rationale: preserves upside from discount/NAV mean reversion while capping drawdown from FX/regulatory shocks.
• Event-driven liquidity capture: Trade trusts with known reporting or dividend policy changes — initiate positions after a factsheet/NSM filing if market reaction is muted. Entry: within 5 trading days of filing. Timeframe: 1–3 months. Target: capture 150–400bp discount compression; size opportunistically (2–4% position each) and stagger entries to limit exposure to sudden EM risk-off.